Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.53 EUR | +0.38% |
|
+1.15% | +12.18% |
05/07 | Berenberg Adjusts Price Target on Corteva to $56 From $54, Maintains Hold Rating | MT |
25/06 | RBC Capital Adjusts Price Target on Corteva to $62 From $64 | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.18% | 3.69TCr | - | ||
-.--% | 1.16TCr | - | B+ | |
+38.17% | 839.23Cr | - | C- | |
-7.91% | 724.69Cr | A | ||
+10.45% | 701.62Cr | B- | ||
-11.22% | 571.47Cr | B+ | ||
-11.66% | 538.17Cr | B | ||
+34.74% | 531.49Cr | B- | ||
-5.22% | 507.21Cr | C+ | ||
+6.45% | 397.37Cr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CTVA Stock
- 2X0 Stock
- Ratings Corteva, Inc.